Author: OurCrowd

[ThetaRay in Business Wire] ThetaRay AI tech to monitor African payments for ARCA

NEW YORK & TEL AVIV, Israel & LAGOS, Nigeria–(BUSINESS WIRE)–ThetaRay, a leading provider of AI-powered transaction monitoring technology, today announced that ARCA, a premier African payment services provider, will implement ThetaRay’s advanced SONAR SaaS anti-money laundering (AML) and sanctions list screening solution for transactions on its open AI-based platform. Read more...

Read More

[Highcon in Printing News] Highcon launches HighConnect performance reporting platform to drive production efficiencies in digital finishing

The first-of-its-kind study examined the impact of analogue and digital creasing lines on the performance of corrugated cardboard and finished boxes.Highcon Systems Ltd. today announces the launch of HighConnect, a cloud-based data information platform that allows users to monitor their Highcon system production performance. Read...

Read More

[D-ID in BusinessWire] Skilldora partners with D-ID, launches first e-Learning platform & app to use A.I. Instructors in the U.S.

FORT MILL, S.C. & TEL AVIV, Israel–(BUSINESS WIRE)–Skilldora, an Ed-Tech startup based in Fort Mill, S.C., known for its modernized app-based eLearning community, today announced a partnership with D-ID, using its Creative Reality™ technology to deliver courses exclusively by A.I. Instructors, also referred to as digitally created humans. Read...

Read More

[Alpha Tau in GlobeNewswire] Alpha Tau announces the acceptance in major peer-reviewed journals (International Journal of Radiation Oncology, Biology, Physics, and Frontiers in Oncology) of two landmark pre-clinical studies demonstrating significant potential synergies between the Alpha DaRT treatment and standard-of-care immunotherapy, chemotherapy and anti-angiogenic therapy

JERUSALEM, Sept. 08, 2022 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”) (Nasdaq: DRTS and DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today the acceptance of two landmark pre-clinical studies in major peer-reviewed journals, both demonstrating the significant potential synergies between Alpha DaRT therapy and standard-of-care solid tumor therapies used today. Read...

Read More

[ReWalk in GlobeNewswire] ReWalk Robotics appoints Michael Lawless as Chief Financial Officer

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Sept. 08, 2022 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq: RWLK) (the “Company” or “ReWalk”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced the appointment of Michael Lawless, CPA, as Chief Financial Officer, effective September 19, 2022. Mr. Lawless brings more than 20 years of experience leading finance and investor relations activities at life science and technology companies to drive greater financial discipline, better strategic decision making, and improved access to capital. Read more...

Read More